GlassScriptPhysician profile
Mahmoud Samman
NPI 1285724237
$41,435.67
in general payments reported to CMS, 2019-2025
49 companies · $8,813 in 2025
The $8,813 reported for 2025 was more than what 96% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $581 · 2021: $797 · 2022: $8,537 · 2023: $5,166 · 2024: $17K · 2025: $8,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $27K · Food and Beverage: $2,995 · Travel and Lodging: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $27,250.01 |
| Food and Beverage | $2,995.02 |
| Travel and Lodging | $445.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $34,843.09 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Nevro Corp. | $845.93 | 2024 | Senza |
| Inari Medical, INC. | $813.94 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $588.97 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Ibsa Pharma INC. | $434.15 | 2020-2024 | Tirosint, Licart, Tirosint |
| Novo Nordisk INC | $421.63 | 2020-2023 | Ozempic, Rybelsus |
| Corcept Therapeutics | $352.00 | 2019-2023 | Korlym |
| Philips North America LLC | $348.84 | 2019-2022 | |
| Terumo Medical Corporation | $283.32 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $259.85 | 2022 | |
| Alexion Pharmaceuticals, INC. | $188.36 | 2022-2023 | Strensiq |
| Medtronic, INC. | $175.95 | 2022-2025 | Venaseal, Abre, Closurefast |
| Amgen INC. | $158.14 | 2019-2020 | |
| Esperion Therapeutics, INC. | $152.45 | 2021-2023 | Nexletol |
| Amarin Pharma, INC. | $124.44 | 2019 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmoud Samman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.